Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,820 | 6,497 | 10,723 | 1,745 | 17,570 |
| Marketable Securities | 794 | 3,817 | 4,973 | 17,588 | 24,059 |
| Receivables | 1,262 | 1,334 | 2,997 | 5,410 | 5,358 |
| Inventories | 1,099 | 1,357 | 3,669 | 3,710 | 4,270 |
| Other current assets | 44 | 973 | 0 | 890 | 0 |
| TOTAL | $8,120 | $15,156 | $23,395 | $30,351 | $52,713 |
| Non-Current Assets | |||||
| PPE Net | 4,092 | 4,398 | 6,683 | 6,298 | 7,364 |
| Intangibles | 4,135 | 4,247 | 4,736 | 4,471 | 16,382 |
| Other Non-Current Assets | 8,390 | 28,926 | 28,517 | 29,291 | 28,570 |
| TOTAL | $16,617 | $37,571 | $39,936 | $40,060 | $52,316 |
| Total Assets | $24,737 | $52,727 | $63,331 | $70,411 | $105,029 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,493 | 1,536 | 1,905 | 3,165 | 2,399 |
| Accrued Expenses | 1,927 | 2,561 | 2,411 | 1,828 | 3,622 |
| Other current liabilities | 740 | 903 | 47 | 1,351 | 292 |
| TOTAL | $6,628 | $8,013 | $6,412 | $8,184 | $25,419 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,837 | 5,278 | 5,223 | 5,269 | 5,169 |
| Deferred Revenues | 263 | 380 | 375 | 338 | 1,179 |
| Other Non-Current Liabilities | 38,951 | 59,769 | 59,697 | 56,478 | 56,355 |
| TOTAL | $45,331 | $65,249 | $65,155 | $61,989 | $61,842 |
| Total Liabilities | $51,959 | $73,262 | $71,567 | $70,173 | $87,261 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,776 | 1,773 | 1,683 | 1,674 | 1,667 |
| Common Shares | N/A | N/A | N/A | N/A | 5 |
| Retained earnings | -189,329 | -182,687 | -170,102 | -161,465 | -143,778 |
| Other shareholders' equity | -5 | -9 | -10 | 0 | -15 |
| TOTAL | $-27,222 | $-20,535 | $-8,236 | $238 | $17,768 |
| Total Liabilities And Equity | $24,737 | $52,727 | $63,331 | $70,411 | $105,029 |